AR066943A1 - A PHARMACEUTICAL COMPOSITION OF MELFALANO - Google Patents

A PHARMACEUTICAL COMPOSITION OF MELFALANO

Info

Publication number
AR066943A1
AR066943A1 ARP080102465A ARP080102465A AR066943A1 AR 066943 A1 AR066943 A1 AR 066943A1 AR P080102465 A ARP080102465 A AR P080102465A AR P080102465 A ARP080102465 A AR P080102465A AR 066943 A1 AR066943 A1 AR 066943A1
Authority
AR
Argentina
Prior art keywords
composition
melphalan
pharmaceutical composition
melfalano
acid solution
Prior art date
Application number
ARP080102465A
Other languages
Spanish (es)
Inventor
Lucio Nunez
Jose Iturraspe
Leonardo Marchitto
Original Assignee
Eriochem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eriochem Sa filed Critical Eriochem Sa
Priority to ARP080102465A priority Critical patent/AR066943A1/en
Priority to PCT/ES2009/070212 priority patent/WO2009150278A1/en
Publication of AR066943A1 publication Critical patent/AR066943A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una composicion farmacéutica de melfalano para preparar una perfusion inyectable estable durante su periodo de almacenamiento, que comprende melfalano y solucion acuosa de ácido. Una formulacion farmacéutica de melfalano que comprende dos composiciones liquidas separadas que se mezclan previamente a ser infundidas en perfusion parenteral, donde la primera composicion líquida es la composicion farmacéutica que comprende melfalano y solucion acuosa de acido y la segunda composicion es una composicion diluyente. Y un kit o conjunto que comprende dicha composicion farmacéutica, dicha composicion diluyente y una jeringa prellenada.A pharmaceutical composition of melphalan to prepare a stable injectable perfusion during its storage period, comprising melphalan and aqueous acid solution. A pharmaceutical formulation of melphalan comprising two separate liquid compositions that are previously mixed to be infused in parenteral infusion, where the first liquid composition is the pharmaceutical composition comprising melphalan and aqueous acid solution and the second composition is a diluting composition. And a kit or assembly comprising said pharmaceutical composition, said diluent composition and a prefilled syringe.

ARP080102465A 2008-06-10 2008-06-10 A PHARMACEUTICAL COMPOSITION OF MELFALANO AR066943A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ARP080102465A AR066943A1 (en) 2008-06-10 2008-06-10 A PHARMACEUTICAL COMPOSITION OF MELFALANO
PCT/ES2009/070212 WO2009150278A1 (en) 2008-06-10 2009-06-08 Pharmaceutical composition of melphalan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP080102465A AR066943A1 (en) 2008-06-10 2008-06-10 A PHARMACEUTICAL COMPOSITION OF MELFALANO

Publications (1)

Publication Number Publication Date
AR066943A1 true AR066943A1 (en) 2009-09-23

Family

ID=41136247

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102465A AR066943A1 (en) 2008-06-10 2008-06-10 A PHARMACEUTICAL COMPOSITION OF MELFALANO

Country Status (2)

Country Link
AR (1) AR066943A1 (en)
WO (1) WO2009150278A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ596515A (en) 2009-05-29 2014-03-28 Cydex Pharmaceuticals Inc Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
AR077384A1 (en) 2010-07-05 2011-08-24 Eriochem Sa AN INJECTABLE PHARMACEUTICAL FORMULATION OF MELFALANO.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727157D0 (en) * 1987-11-19 1987-12-23 Wellcome Found Pharmaceutical formulations
SI1478339T1 (en) * 2002-02-22 2008-10-31 Schering Corp Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same

Also Published As

Publication number Publication date
WO2009150278A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
PH12019500517A1 (en) Long-acting formulations of insulins
EA201491685A1 (en) PREPARATION FOR INJECTIONS
WO2007020085A3 (en) Compositions containing taxane derivatives for intravenous injection
MX352823B (en) Protein formulations containing amino acids.
MY159450A (en) High concentration antibody-containing liquid formulation
BR112015008186A2 (en) formulation of a stable, low viscosity antibody
BR112014009022A2 (en) etanercept formulations stabilized with sugar and polyol combinations
PH12014502778B1 (en) Antibody formulation
RU2014147365A (en) APPLICANT INJECTED COMPOSITIONS
BR112013016770A2 (en) pharmaceutical formulation, biopharmaceutical drug, pre-filled syringe or pen, use of a pharmaceutical formulation
FI20120287A (en) Water composition containing resin acids to be used as antimicrobial treatment agent and additive
ATE516835T1 (en) SYRINGE ASSEMBLY FOR A DILUNER/MEDICINAL MIXTURE
WO2012035480A3 (en) Pharmaceutical compositions of curcumin
PE20151426A1 (en) SOLUTION TO PRESERVE VASCULAR DUCTS
AR066943A1 (en) A PHARMACEUTICAL COMPOSITION OF MELFALANO
HRP20150815T1 (en) Stable ready to use injectable paracetamol formulation
WO2014058329A8 (en) Compositions based on hypophyseal hormones for adding to infusion fluids
EA201291463A1 (en) COMPOSITIONS FOR INFANTION OF LANTIBIOTIC TYPE B
RS54362B1 (en) Ibuprofen intravenous infusion
EA201391512A1 (en) SOLID PHARMACEUTICAL COMPOSITION
MX2014013083A (en) Injectable pharmaceutical composition of dexketoprofen and tramadol.
CO6470880A2 (en) SOLUTIONS FOR INFUSION AND INJECTION OF IPAMORELINE DIACETATE.
WO2011104037A3 (en) Process for preparing a ready-to-use product which can be metered
WO2012157921A3 (en) Composition for transdermal administration, containing rivastigmine or salt thereof
TH103208A (en) New type of tags

Legal Events

Date Code Title Description
FB Suspension of granting procedure